Literature DB >> 9538966

Optimal time of administration of insulin lispro. Importance of meal composition.

M W Strachan1, B M Frier.   

Abstract

OBJECTIVE: To compare the glucodynamics of pre- and postprandial administration of insulin lispro using test meals of differing composition. RESEARCH DESIGN AND METHODS: Twenty subjects with IDDM were studied on four separate occasions. Ten subjects ingested high-carbohydrate and high-fat breakfasts with a large liquid component, and 10 subjects ingested high-carbohydrate and high-fat breakfasts in a more solid form. With each meal, insulin lispro was injected 10 min preprandial on one occasion and 20 min postprandial on another. The magnitude and temporal pattern of postprandial glucose excursions were observed.
RESULTS: With all meal types studied, postprandial blood glucose excursions were significantly smaller when insulin lispro was administered preprandially (P < 0.05). With both high-carbohydrate meals and the liquid high-fat meal, preprandial administration of lispro was associated with modest postprandial increments of blood glucose. With the solid high-fat meal, preprandial lispro produced a cumulative decline in postprandial blood glucose, whereas blood glucose rose when lispro was administered postprandially.
CONCLUSIONS: For meals with a high carbohydrate content, the optimal time of administration of lispro is preprandial. However, for meals with a high solid fat content, postprandial administration of lispro may be preferable.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538966     DOI: 10.2337/diacare.21.1.26

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  7 in total

Review 1.  Insulin analogues and management of diabetes mellitus.

Authors:  B Vaidyanathan; P S Menon
Journal:  Indian J Pediatr       Date:  2000-06       Impact factor: 1.967

2.  Absorption patterns of meals containing complex carbohydrates in type 1 diabetes.

Authors:  D Elleri; J M Allen; J Harris; K Kumareswaran; M Nodale; L Leelarathna; C L Acerini; A Haidar; M E Wilinska; N Jackson; A M Umpleby; M L Evans; D B Dunger; R Hovorka
Journal:  Diabetologia       Date:  2013-02-23       Impact factor: 10.122

Review 3.  Insulin lispro: a review of its use in the management of diabetes mellitus.

Authors:  Dene Simpson; Paul L McCormack; Gillian M Keating; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Insulin analogues: new therapies for type 2 diabetes mellitus.

Authors:  M Angelyn Bethel; Mark N Feinglos
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

Review 5.  New insulin analogues and routes of delivery: pharmacodynamic and clinical considerations.

Authors:  Paris Roach
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 6.  Guidelines for using insulin lispro.

Authors:  E L Toth; K C Lee
Journal:  Can Fam Physician       Date:  1998-11       Impact factor: 3.275

7.  Influence of and optimal insulin therapy for a low-glycemic index meal in children with type 1 diabetes receiving intensive insulin therapy.

Authors:  Rochelle L Ryan; Bruce R King; Donald G Anderson; John R Attia; Clare E Collins; Carmel E Smart
Journal:  Diabetes Care       Date:  2008-05-05       Impact factor: 19.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.